Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Uncomplicated Malaria in Benin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* 6-119 months old~* fever or history of fever of less than 24 hours~* p falciparum parasitemia \> 1000 trophozoïtes/µL~* informed consent signed~Exclusion Criteria:~* \< 5 kg~* danger or severity signs of malaria~* known underlying chronic disease~* Hb \< 5g/dL~* adequate malaria treatment taken within 3 days before visit

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 119 Months
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): sulfadoxine-pyrimethamine
- 2 (Type: ACTIVE_COMPARATOR): artemether-lumefantrine
- 3 (Type: ACTIVE_COMPARATOR): amodiaquine-artesunate coformulation

Based on this trial design, predict the completion outcome and termination type (if applicable).